OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Abrocitinib: First Globally Approved Selective Janus Kinase-1 Inhibitor for the Treatment of Atopic Dermatitis
Surya K. De
Current Medicinal Chemistry (2023) Vol. 30, Iss. 38, pp. 4278-4282
Closed Access | Times Cited: 6
Surya K. De
Current Medicinal Chemistry (2023) Vol. 30, Iss. 38, pp. 4278-4282
Closed Access | Times Cited: 6
Showing 6 citing articles:
Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer
Xue Chen, Qinfan Yao, Xinyu Gu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 190
Xue Chen, Qinfan Yao, Xinyu Gu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 190
Potential applications of JAK inhibitors, clinically approved drugs against autoimmune diseases, in cancer therapy
Xiaohuan Wei, Yuanyuan Liu
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 4
Xiaohuan Wei, Yuanyuan Liu
Frontiers in Pharmacology (2024) Vol. 14
Open Access | Times Cited: 4
Radiation exposure induced blood-brain barrier injury via mitochondria-mediated sterile inflammation
Peng Wang, Jiayue Liu, Min Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Peng Wang, Jiayue Liu, Min Zhang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Synthesis and clinical application of new drugs approved by FDA in 2022
Jingyi Zhang, Yatao Wang, Lu Sun, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 9
Jingyi Zhang, Yatao Wang, Lu Sun, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 9
Oral abrocitinib in the treatment of refractory dissecting cellulitis of the scalp: A case report
Sha Jin, Chao Yue, Shiwen Wang, et al.
The Journal of Dermatology (2024) Vol. 51, Iss. 10
Closed Access | Times Cited: 2
Sha Jin, Chao Yue, Shiwen Wang, et al.
The Journal of Dermatology (2024) Vol. 51, Iss. 10
Closed Access | Times Cited: 2
Atopic Dermatitis and Abrocitinib: Unraveling the Therapeutic Potential
Ayesha Abdul Qadir Memon, Habibun Nisa, Muhammad Osama, et al.
Current Signal Transduction Therapy (2024) Vol. 19, Iss. 2
Closed Access
Ayesha Abdul Qadir Memon, Habibun Nisa, Muhammad Osama, et al.
Current Signal Transduction Therapy (2024) Vol. 19, Iss. 2
Closed Access
